https://cdn1.img.sputniknews.com/img/07e4/09/0a/1080419598_0:110:3321:1977_1200x675_80_0_0_6b1bd9926956c4e62688988ed1f71720.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/us/202010101080727372-us-signs-486mln-deal-with-astrazeneca-to-secure-100000-doses-of-antibody-treatment—hhs/ WASHINGTON (Sputnik) – The Trump administration has signed an agreement with biopharmaceutical giant AstraZeneca to develop and secure 100,000 doses of a cocktail antibody treatment for the novel coronavirus disease (COVID-19), Health and Human Services said in a press release. The release said the company’s antibody treatment, which is called AZD7442, is a cocktail of two monoclonal antibodies and will need approval from the Food and Drug Administration. “The Biomedical Advanced Research and Development Authority part of the HHS Office of the Assistant Secretary for Preparedness and Response, collaborated with the DoD [Defense Department] […]
AstraZeneca
Competitors in the Covid-19 vaccine race are publishing clinical protocols in hopes of securing lucrative emergency approval, which Russia’s Sputnik V was previously attacked for seeking. This time, however, the media are quiet. The frontrunners in the US and western Europe’s quest to develop a coronavirus vaccine – Pfizer, AstraZeneca, and Moderna – have published their trial protocols in response to growing public unease over the rapid rollout of the promised coronavirus magic bullet. They reveal an overwhelming emphasis on being first to secure emergency approval from the relevant regulators, suggesting the companies’ goal is maximum profits rather than ensuring the […]
The Testing of the chimpanzee adenovirus-based vaccine had been repeatedly called into question for the “dangerous” lack of sufficient trials on chimp viruses as well as the unclear consequences of the new technology. The trials of AstraZeneca vaccine candidate remain on hold in the US. Days after AstraZeneca halted clinical trials of its COVID-19 vaccine over the case of unexplained neurological illness in one volunteer taking part in the study, the British-Swedish pharmaceutical company released an 111-page trial blueprint, which promises an anti-coronavirus drug with “50% effectiveness”. That was the first time AstraZeneca revealed the second case of serious illness by […]
by Fabio Giuseppe Carlo Carisio for VT Europe The devil makes the pots but not the lid. While the theory of the genetically modified organism built in the laboratory is becoming more and more concrete on the origin of the SARS-2 virus, here is the second hitch for one of the leading companies in the production of vaccines, the AstraZeneca of Anglo-Swedish ownership but actually controlled by the same American and Zionist shareholders of the Weapons Lobby (as demonstrated in previous investigations). WUHAN-GATES – 15. EU-Italy Covid Vaccine’ Business in Gates-Big Pharma’s Dirty Hands Big Pharma stumbles upon a second […]
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal of uncertainty remains about […]
UPDATE ON SEPTEMBER, 11 The COVID-19 vaccine participant whose mysterious illness stopped the AstraZeneca coronavirus vaccine trials is reported to be an inflammatory syndrome known as transverse myelitis which may lead to paralysis. According to agreements with governments, the vaccine manufacturer cannot be legally held responsible for the side-effects of the coronavirus vaccine, for the ongonign pandemic emergency. The vaccine candidate, known as AZD1222 and developed with researchers at Oxford University Jenner Institue, was considered one of the promising. In April and May, researchers performed a combined Phase I and II trial that showed that the vaccine was safe, produced no unusual side-effects, […]
https://cdn1.img.sputniknews.com/img/07e4/08/1c/1080306907_0:306:3072:2034_1200x675_80_0_0_af8593d0dd04bfaec4f6a587b22cda3d.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/society/202009091080413621-astrazeneca-rejects-claim-covid-19-trial-was-halted-over-case-of-transverse-myelitis/ British-Swedish multinational pharmaceutical company AstraZeneca has rejected claims that its third round of trials for a COVID-19 vaccine was halted over a case of transverse myelitis, a neurological disorder characterized by inflammation of both sides of a section of the spinal cord. According to the company, its COVID-19 vaccine trial was paused in July after a volunteer was found to have multiple sclerosis, a disease that causes damage to the central nervous system. However, the diagnosis was found to be unrelated to the vaccine. “Reports claiming to be based on comments made earlier today […]
https://cdn1.img.sputniknews.com/img/105689/07/1056890761_0:114:2200:1352_1200x675_80_0_0_2932208db7d91200744ca8080e688a5d.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/uk/202008251080270125-uks-astrazeneca-begins-human-trial-of-covid-19-treatment-using-monoclonal-antibodies/ LONDON (Sputnik) – UK-based pharmaceutical company AstraZeneca announced on Tuesday that it had begun the human trial of a new treatment for COVID-19 using a combination of two monoclonal antibodies. “The first participants have been dosed in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) in development for the prevention and treatment of COVID-19,” the multinational giant said in a press release. Up to 48 healthy people aged 18 to 55 years will take part in the first stage of the trial, aimed at evaluating the safety, tolerability and […]
Brazil continues to struggle against the COVID-19 pandemic, which has severely struck the country, with more than 3.5 million confirmed cases and over 112,000 COVID-related deaths. Brazilian academic Fabio Sobral has shed light on the internal fight between the federal and local governments as well as the unfolding “vaccine race” in the country. The country’s President Jair Bolsonaro has been repeatedly subjected to criticism for his handling of the pandemic by international and domestic observers. Speaking to The Guardian last Saturday, ex-Brazilian Health Minister Luiz Henrique Mandetta, who was sacked by the president in April, lashed out at Bolsonaro for leading […]
Earlier this month France, Germany, Italy and the Netherlands joined forces to form the “Inclusive Vaccine Alliance”, in order to have a stronger negotiating position in the race for a coronavirus vaccine. The contract agreement with AstraZeneca is the alliance’s first result in securing a potential coronavirus vaccine for European countries. The Vaccine Alliance formed by France, Germany, Italy and the Netherlands has signed a contract with British-Swedish pharmaceutical company AstraZeneca to supply a coronavirus vaccine for Europe, Italy’s Health Minister said on Saturday. The contract is for 400 million doses of the vaccine which was developed at the University of […]